Isochron

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Isochron

Understanding Isochron

Isochron is a pharmaceutical formulation containing isosorbide dinitrate, which belongs to a class of medications known as nitrates. It is primarily utilized in the management of certain cardiovascular conditions, specifically relating to the heart's blood supply and the prevention of chest pain symptoms.

Mechanism of Action

The medication works by relaxing the smooth muscles within the walls of the blood vessels. When these muscles relax, the blood vessels widen—a process known as vasodilation. This expansion occurs in both arteries and veins, though its effects are particularly significant in the systemic veins and coronary arteries.

By dilating the blood vessels, Isochron facilitates several physiological changes:

  • Reduced Preload: It decreases the volume of blood returning to the heart, which lowers the pressure within the heart chambers.
  • Reduced Afterload: It lowers the systemic vascular resistance, making it easier for the heart to pump blood to the rest of the body.
  • Improved Oxygen Delivery: It enhances blood flow to the heart muscle itself by dilating the coronary arteries, ensuring a better balance between oxygen supply and demand.

Clinical Applications

Isochron is indicated for the prevention of angina pectoris, a type of chest pain caused by reduced blood flow to the heart. It is important to note that this medication is designed as a prophylactic measure. This means it is taken on a regular schedule to reduce the frequency and severity of angina attacks over the long term, rather than being used to provide immediate relief during an acute episode.

Physical Characteristics

As a therapeutic agent, Isochron is typically administered in oral tablet forms. The formulation is engineered to release the active isosorbide dinitrate into the bloodstream to maintain the necessary vascular relaxation required for cardiac support. The specific regimen and duration of use are determined based on individual cardiovascular health requirements and the clinical assessment of the underlying heart condition.

What side effects are possible with Isochron?

Possible Side Effects and Safety Information

The safety profile of Isochron (Isosorbide Dinitrate) is officially documented by government regulatory bodies and primarily reflects its powerful vasodilatory action. Side effects are classified by frequency and System-Organ Class (SOC) according to established regulatory standards.


Frequency-Classified Adverse Reactions

The most frequently reported effect, classified as Very Common, is headache. These headaches are often noted to be most prominent at the initiation of treatment and typically lessen with continued use. Effects classified as Common include dizziness, hypotension (low blood pressure), tachycardia (increased heart rate), nausea, and facial flushing.

Classification System-Organ Class Focus Specific Effects
Very Common Nervous System Headache
Common Vascular / Nervous System Hypotension, Dizziness, Facial Flushing
Uncommon Cardiac / Vascular Disorders Syncope (fainting), Exacerbation of Angina Pectoris
Rare Blood & Lymphatic System Methemoglobinemia

Serious Reactions and Safety Constraints

The label documents the potential for profound hypotension and circulatory collapse (shock), which are considered serious adverse reactions. A critical safety restriction involves the absolute contraindication with co-administration of Phosphodiesterase type 5 (PDE5) inhibitors due to the risk of severe, life-threatening hypotension.

Population-Specific Notes caution against use in individuals with severe anemia or closed-angle glaucoma. Furthermore, regulatory texts note the potential for tolerance (diminished effect) with continuous exposure, a duration-related pattern that necessitates a defined nitrate-free interval to maintain the drug's safety and effectiveness.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdosage with Isochron (Isosorbide dinitrate) is documented in regulatory prescribing information to cause symptoms resulting from excessive vasodilation and subsequent low blood pressure.

Documented Overdose Manifestations

The signs of an overdose may include profound hypotension (dangerously low blood pressure), severe throbbing headache, dizziness, syncope (fainting), confusion, and tachycardia (fast or pounding heartbeat). Gastrointestinal issues like nausea, vomiting, and bloody diarrhea, as well as vision disturbances, have also been officially documented.

Serious or Life-Threatening Outcomes

Acute overdosage can lead to life-threatening conditions, including circulatory collapse (shock), respiratory failure, seizure, and coma. A critical documented risk is methemoglobinemia, a condition where the blood's oxygen-carrying capacity is reduced, often signaled by cyanosis (bluish discoloration of the skin and lips).

Required Emergency Action

Official regulatory documents emphasize that any suspected overdose requires immediate and urgent medical attention. Individuals should contact a Poison Control Center or local emergency services (such as 911) right away. Immediate medical help is required if the person has collapsed, has trouble breathing, or has a seizure. Treatment in a medical setting focuses on supportive care, management of severe hypotension, and the use of the specified antidote, Methylene Blue, if significant methemoglobinemia is confirmed.

Therapeutic Uses of Isochron

What Isochron Treats: Main Uses and Benefits

Isochron is a medication primarily used for the management of symptoms associated with ischemic heart disease and certain presentations of heart failure.

This medication is commonly used for the management of angina (chest pain) in people who have coronary artery disease. It is also applied with other medications to treat heart failure.


Easing Angina Pectoris and Ischemic Chest Pain

This medication is commonly used to help manage the distressing symptoms related to physical discomfort known as angina pectoris, which is the pain or tightness arising from temporary insufficient blood flow to the heart muscle. It provides a core therapeutic benefit by assisting with symptomatic relief during sudden episodes of chest discomfort. This therapeutic domain is used in situations involving certain distressing symptoms.


Long-Term Management and Prevention of Attacks

Isochron is relevant for use in conditions characterized by periods of heightened symptoms, specifically for the prophylactic management of angina to reduce the frequency and severity of recurrent attacks in patients with long-standing symptoms. This application is used to help patients maintain a sense of stability when symptoms are more noticeable, supporting general well-being during symptomatic phases.


Quick Fact: Support for Chest Discomfort
Primary Use Focus: Support for ischemic chest pain and reduction of angina attack frequency
Symptom Scope: Manages pain, pressure, and shortness of breath related to cardiac strain
Context: Relevant for both acute episodic relief and chronic, long-term stability

Supportive Therapy for Congestive Heart Failure Symptoms

The medication is applied in clinical settings that involve acute or unstable symptom patterns, offering adjunctive symptomatic support in the management of heart failure. It helps address symptom clusters that may become intense or disruptive, such as pulmonary congestion and shortness of breath, providing supportive relief when symptoms may be more noticeable.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

The use of Isochron (Isosorbide Dinitrate) is officially established for adults and is subject to mandatory exclusions defined by regulatory bodies.

Absolute Contraindications

The medicine is contraindicated in patients with a documented hypersensitivity to any nitrate, including isosorbide dinitrate. Absolute prohibition applies to individuals concurrently taking Phosphodiesterase type 5 (PDE5) inhibitors (such as sildenafil) or the sGC stimulator riociguat due to the risk of severe hypotension. Furthermore, Isochron must not be used in cases of cardiogenic shock, severe anemia, or pre-existing conditions like intracranial hypertension or obstructive cardiomyopathy.

Restricted and Age-Related Use

  • Pediatric Patients: Safety and effectiveness have not been established in children or adolescents.
  • Older Adults: Use is permitted, but caution is required due to the increased frequency of age-related decline in hepatic or renal function and susceptibility to hypotensive effects.
  • Pregnancy/Lactation: Use is not recommended and is restricted to situations where the expected benefit is judged to outweigh the documented potential risk. Caution is also necessary for patients with existing hypotension or hypovolaemia.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Prohibited Combinations (Contraindicated)

The co-administration of Isochron (Isosorbide Dinitrate) with specific classes of medicines is formally contraindicated in regulatory documents due to the potential for severe symptomatic hypotension, syncope, or myocardial ischemia. These combinations represent the most severe interaction constraint in the official profile.

  • Phosphodiesterase-5 (PDE5) Inhibitors: This class, which includes sildenafil, tadalafil, vardenafil, and avanafil, is strictly prohibited for concurrent use.
  • Soluble Guanylate Cyclase (sGC) Stimulators: This class, which includes riociguat, is also prohibited for co-administration.

Additive Pharmacodynamic Effects

Regulatory documents define interactions based on additive vasodilating effects that can potentiate the blood pressure-lowering effect of Isochron.

  • Antihypertensive Agents: Classes of medications used to lower blood pressure, such as beta-adrenergic blockers and calcium channel blockers, may result in additive hypotensive effects. Specifically, marked symptomatic, orthostatic hypotension has been reported with calcium channel blockers.
  • Other Agents: Phenothiazines and other general vasodilators are also documented as carrying a risk for these additive effects.
  • Alcohol (Ethanol): Alcohol consumption is noted in regulatory information to exhibit additive vasodilating effects, which may intensify hypotension.

The official interaction structure relies on defining these two levels of risk: absolute prohibition (contraindication) and caution due to documented pharmacodynamic potentiation.

Mechanism of Action

Nitric Oxide Signaling and Vascular Relaxation

Isochron (Isosorbide Dinitrate) works as a prodrug that is bioactivated within vascular cells to release Nitric Oxide (NO), which is the key mechanistic effector. The NO then activates the enzyme soluble Guanylyl Cyclase (sGC), leading to a rise in the second messenger cyclic Guanosine Monophosphate (cGMP). This cGMP signaling cascade ultimately drives the relaxation of vascular smooth muscle by inhibiting the cellular contraction process.


Modulation of Cardiac Preload and Afterload

The resulting vasodilation exerts its primary influence by selectively relaxing the venous capacitance vessels throughout the body. This preferential effect causes blood to pool peripherally, thereby reducing the volume of blood returning to the heart (Preload reduction). At higher concentrations, the mechanism also reduces Afterload by dilating arterioles, lowering the resistance the heart must overcome, and also causes direct dilation of coronary arteries.


Mechanism Constraint: Nitrate Tolerance

A functional constraint of this mechanism is the potential for nitrate tolerance to develop upon continuous exposure. This loss of effectiveness is hypothesized to result from either a decline in the cellular ability to bioactivate the prodrug and release NO, or a desensitization of the downstream target, sGC. This mechanistic limitation requires a regular nitrate-free interval to allow the recovery of the cellular components necessary for the mechanism to reactivate.

Dosage and Administration Information

How to Use Isochron: Official Administration Guidelines

Isochron (Isosorbide Dinitrate) is administered via the oral route for daily management and sublingually for rapid action, as directed by official prescribing information. Correct use depends on the dosage form and adherence to strict scheduling.


Administration Routes and Standard Dosing

Administration Type Standard Adult Dosing (Prophylaxis) Administration Notes
Oral Tablet (Immediate-Release) 5 mg to 40 mg, two or three times daily Taken with or without food. Follow a cyclic schedule.
Extended-Release Capsule/Tablet 40 mg to 160 mg, once or twice daily Must be swallowed whole; do not crush or chew.
Sublingual Tablet (Rapid Action) 2.5 mg to 5 mg Dissolved under the tongue; not to exceed 3 doses in 15–30 minutes for acute use.

Essential Procedural Constraints

To maintain the drug's effectiveness over time, the official labeling mandates a nitrate-free interval (a daily period without medication). This scheduling constraint requires that dosing times be structured to ensure an uninterrupted period of at least 14 hours (for immediate-release forms) or longer (for extended-release forms) without the drug.

Treatment is typically initiated at the lowest effective dose and titrated upward to the maintenance dose, based on the prescribed regimen. For older adults, starting with a lower dose is often recommended. No major dose adjustments are explicitly required in the prescribing information for patients with renal or hepatic impairment.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Isochron

Evidence for Angina Pectoris (Stable Chest Pain) Studies

The research for Isochron (Isosorbide Dinitrate) includes numerous Randomized Controlled Trials (RCTs) and meta-analyses that were applied in studies examining patient-reported experiences related to chest discomfort. These studies focused on adult populations already diagnosed with stable angina and coronary artery disease. Research was applied in research contexts involving fluctuating or episodic symptom patterns.

Studies monitored changes and described patterns observed in the cohorts over short-term periods. The research examined changes measured during the study period, such as exercise capacity—the total time a patient was monitored for symptoms during exertion. Studies also monitored outcomes related to physical discomfort, specifically tracking the frequency of angina episodes reported per week. This evidence contributes to understanding short-term symptom patterns in conditions where symptoms may vary in intensity.

How the Short-Term Effect Was Studied

The research explored short-term symptom changes, often tracking the effects of a single dose for up to eight hours. Multi-dose studies were also conducted during periods of increased symptom activity, observing responses over defined time intervals of several weeks. However, one key area that research describes is the development of pharmacological tolerance; studies monitored whether continuous, high-dose use was associated with patterns of reduction in the initial measurements of effect. Studies monitored whether specific dosing schedules designed to create a drug-free interval would alter symptom patterns observed during the research period.


Evidence for Adjunctive Support in Heart Failure Research

Isochron was evaluated in large-scale Randomized Controlled Trials (RCTs) and observational cohort studies for its role in supportive care for patients with Heart Failure with Reduced Ejection Fraction (HFrEF). These research contexts involved fluctuating or unstable symptoms, and studies explored outcomes related to systemic or functional imbalance. Key outcomes monitored were those reflecting daily functioning, specifically tracking patient survival (all-cause mortality) and rates of hospitalization for heart failure exacerbations.

Research Context: Single Agent vs. Combination Therapy

A critical part of the evidence landscape for heart failure involves trials that utilized a fixed-dose combination of Isochron with another medicine, hydralazine. The most extensive evidence base included studies that monitored all-cause mortality and heart failure hospitalization rates within the context of combination therapy. Research describes that the most consistent findings for the combination were reported for a specific subgroup of African-American patients with HFrEF, which highlights the specific conditions under which these study results reflect.

Frequently Asked Questions (FAQ)

Common questions about Isochron (FAQ)

Q: What is Isochron used for besides the main condition?

A: Regulatory documents indicate that Isochron (Isosorbide Dinitrate) is approved for the treatment and prevention of chest pain (angina pectoris). It is also approved for use in combination with other medicines for the management of heart failure.

Q: Are there any long-term effects of taking Isochron?

A: A well-documented constraint of using Isochron long-term is the potential for nitrate tolerance, where the medicine loses effectiveness over time. To help prevent this, official dosing schedules typically mandate a daily drug-free interval—a period without the medicine—to restore its full effect.

Q: How quickly should I feel a difference after starting Isochron?

A: The onset of effect depends on the form of the medicine you take. Sublingual tablets are designed to work rapidly for acute action. Official information states that oral immediate-release tablets begin working in about 30 minutes, while extended-release forms take longer to reach their full effect.

Q: Why is Isochron not recommended for people with certain heart problems?

A: It is strictly prohibited if you are taking certain other drugs used for pulmonary hypertension or erectile dysfunction. It is also used with caution in people with low blood pressure (hypotension) or those who have had a recent heart attack, as the drug can severely lower blood pressure.

Q: Why does the packaging for Isochron have a specific warning?

A: Warnings are required on the labeling and packaging to highlight life-threatening risks for patient safety. This includes the absolute prohibition of taking Isochron with certain medicines, such as Phosphodiesterase-5 (PDE5) inhibitors, due to the risk of severe blood pressure drop.

Q: Do I need to avoid certain activities while on Isochron?

A: Official information lists side effects such as dizziness, lightheadedness, or fainting (syncope). Because of these effects, patients should be aware that activities requiring full alertness, such as driving or operating machinery, may be affected, particularly when treatment is first initiated.

Q: Can Isochron be stored in the bathroom medicine cabinet?

A: Isochron must be stored at controlled room temperature (15 C to 30 C or 59 F to 86 F). Regulatory guidance advises against storing the medicine in locations prone to high heat and moisture fluctuations, such as a bathroom medicine cabinet, as these conditions may reduce the medicine’s stability.

Q: Why do doctors prescribe Isochron for some people but not others?

A: The prescribing decision is based on whether an individual has one of the medicine’s approved conditions, such as angina or heart failure. It is also determined by the presence of contraindications, which are conditions or other medicines (like certain prohibited drugs) which would pose a significant safety risk according to official labeling.

Q: What is the typical timeframe for most common side effects to go away?

A: The most frequent side effect, headache, typically lessens and may resolve after continued use, often within the first few days of starting treatment. Other common side effects like dizziness and facial flushing usually follow a similar pattern as the body adjusts to the medicine.

Q: How often do people need to adjust their Isochron dose?

A: The dosage is initially adjusted (a process called titration) upward based on the patient’s clinical response and needs. Once a stable maintenance dose is established, further adjustments are typically only made based on a physician’s assessment of recurring symptoms or the development of tolerance.

Q: What organs does Isochron mainly affect?

A: Isochron primarily affects the cardiovascular system. Its mechanism of action is to relax the smooth muscles of the veins and arteries (blood vessels), which reduces the amount of pressure and work the heart has to handle.

Q: Does Isochron cause problems with sleep?

A: Official reports on side effects classify drowsiness or sleepiness as a possible effect. However, this is not one of the most common or frequent side effects reported.

Q: Can Isochron be taken with common over-the-counter pain relievers?

A: According to regulatory sources, Paracetamol (acetaminophen) is generally considered safe to take with Isochron. However, regulatory warnings advise caution regarding the regular use of non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen, as these medications may potentially worsen underlying heart conditions.

Q: Why is a specific ingredient listed as a precaution for Isochron?

A: Some forms of Isochron may contain inactive ingredients, known as excipients, such as lactose. In regulatory texts, patients who have rare hereditary problems of sugar intolerance are noted as a population requiring caution. Official labeling indicates that use is contraindicated in these specific circumstances.

Q: Is Isochron a controlled substance?

A: No. Isochron (Isosorbide Dinitrate) is not classified as a controlled substance under the US Controlled Substances Act (CSA) or similar international drug schedules.

Q: Does Isochron interact with herbal supplements?

A: Official regulatory studies provide insufficient information to definitively determine the safety of combining Isochron with most herbal remedies or dietary supplements. Due to the lack of available data, there is an inherent uncertainty regarding potential interactions with herbal products.

Q: If I stop taking Isochron, will the original symptoms return?

A: Abruptly stopping Isochron may be associated with an exacerbation or worsening of chest pain (angina). The official labeling specifies that if treatment is to be discontinued, the dosage is generally reduced gradually (tapered) under the direction of a healthcare professional.

Q: Can Isochron be used by teenagers?

A: According to official regulatory labeling, the safety and effectiveness of Isochron have not been established in pediatric patients (children and adolescents).

Q: Does Isochron require special monitoring or blood tests?

A: No routine blood work or laboratory monitoring is generally required for the safe use or dose titration of Isochron. Monitoring is primarily clinical and involves checking for changes in symptoms, blood pressure, and heart rate.

Q: Are there any known issues with Isochron and vision?

A: Isochron is contraindicated (not to be used) in patients with closed-angle glaucoma because it may increase eye pressure. Blurred vision is also noted as a possible, though rare, side effect in safety documentation.

Q: Is the brand name Isochron the same as the generic version?

A: Isochron is a brand name for the generic medicine Isosorbide Dinitrate. Generic versions must meet the same quality, strength, purity, and stability standards as the brand-name drug and are considered bioequivalent by the FDA.

Q: Is Isochron safe to take during the summer heat?

A: Because Isochron is a vasodilator (it widens blood vessels), its effects may be amplified by environmental factors like intense heat or fever. This can increase the risk of dizziness and low blood pressure (hypotension).

Q: Is there any research looking at Isochron and pregnancy outcomes?

A: Official regulatory information states there are no adequate and well-controlled studies in pregnant women. Animal studies suggest evidence of embryotoxicity. Labeling indicates that the use of the drug during pregnancy is generally restricted to situations where the potential benefit is determined to justify the potential risk to the fetus.

Q: What are the most common reasons people discontinue Isochron treatment?

A: The most frequently reported adverse effect is headache, which often leads patients to discontinue treatment. Other common reasons relate to the drug's primary side effects, such as hypotension (low blood pressure) or the development of nitrate tolerance.

Q: Why are people with allergies sometimes told not to take Isochron?

A: Isochron is strictly contraindicated (prohibited) for anyone with a known hypersensitivity or allergy to the active ingredient, isosorbide dinitrate, or to any other organic nitrate or nitrite medicine.

Q: How long does Isochron stay in the body?

A: According to pharmacokinetic data, the elimination half-life (the time it takes for half the medicine to leave the bloodstream) of Isochron is approximately one hour. However, plasma concentrations can be detected for several hours after chronic dosing.

Q: Does Isochron have any pediatric studies?

A: Regulatory documents confirm that studies supporting the safety and effectiveness of Isochron in the pediatric patient population (children and adolescents) have not been established.

How should Isochron be stored and disposed of?

How to Store and Dispose of Isochron (Isosorbide Dinitrate)

The official storage conditions for Isochron tablets require specific environmental control to maintain product stability.


Storage Conditions

Requirement Constraint (Official Labeling)
Temperature Store at controlled room temperature (15 C to 30 C or 59 F to 86 F); Keep from freezing.
Protection Keep tightly closed in the original container, away from excess heat, moisture, and light.
Child Safety Keep out of the reach of children.

Disposal Instructions

Official disposal directives require patients to ask a healthcare professional or pharmacist how to properly discard any unused or outdated medicine. Disposal should utilize community drug take-back programs. If a program is unavailable, the medicine should be mixed with an undesirable substance, sealed in a bag, and thrown into the household trash; do not flush.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Isochron found in:

A-Z Index: